Division of Hematology and Oncology: Department of Medicine: Feinberg School of Medicine: Northwestern University

The Division of Hematology and Oncology is focused on improving patients’ therapeutic options and quality of life while working to better prevent, diagnose and treat cancer and hematologic disorders.

“Our division houses laboratory-based investigators focused on a broad array of topics, including chemoprevention, cell signal pathways, epigenetics, immune-modulation, and nanotechnology theranostics.”

– William J. Gradishar, MD

Read Message from the Chief

What We Do

Faculty: Meet the Team

View individual profiles of our faculty members and learn about their research and clinical specialties.




See All Faculty

Ami N Shah

Assistant Professor of Medicine (Hematology and Oncology)

I am dedicated to providing the high-quality and compassionate care for patients with breast cancer. I am interested in clinical research with a focus on developing clinical trials of novel agents for the treatment of all stages of breast cancer and investigating biomarkers to guide therapy decisions.

Bin Zhang

Professor of Medicine (Hematology and Oncology) and Microbiology-Immunology

Cancer immunology and immunotherapy. The Zhang laboratory functions as an integrated translational research program with the goal of designing and developing new immunotherapies and immunologic strategies for cancer treatment. The ongoing projects are focused on dissecting the molecular mechanisms used for tumor immune evasion based on the cutting-edge technical platforms.

Huiping Liu

Associate Professor of Pharmacology and Medicine (Hematology and Oncology)

The Liu lab studies the molecular mechanisms underlying cancer stem cells (CSCs) and metastasis through four ongoing interactive basic and translational research projects: (1) to understand CSCs in metastasis using cutting-edge single cell sequencing and CRISPR/Cas9 gene editing technologies; (2) to image CSC behavior and interactions with immune cells during metastasis using bioluminescence imaging and intravital imaging systems; (3) to target CSCs with novel therapeutics delivered by exosomes and nanoparticles; (4) to develop circulating tumor cells (CTCs) and circulating exosome-based bioma…

Jindan Yu

Professor of Medicine (Hematology and Oncology) and Biochemistry and Molecular Genetics

The primary research focus of the lab is to understand aberrant transcriptional and epigenetic regulation of prostate cancer. We utilize high-throughput genomic techniques in combination with bioinformatics/statistical analysis to generate hypothetical concepts. We then test these hypotheses using traditional molecular or cellular biological approaches and examine the functional relevance of innovative mechanisms using in vitro cell line and in vivo mouse models. Transcription factors of particular interest to us include androgen receptor (AR), FoxA1, Polycomb group protein (EZH2), and the Ets…

Peng Gao

Research Assistant Professor of Medicine (Hematology and Oncology)

PhD – Medical University of South Carolina (MUSC); Post-doctoral scholar – Proteomics & Mass Spectrometry Center at MUSC; Staff Scientist – Proteomics Center of Excellence at Northwestern University; Operation Director – Metabolomics Core Facility of RHLCCC at Northwestern University

Leonidas C Platanias

Professor of Medicine (Hematology and Oncology) and Biochemistry and Molecular Genetics

chronic leukemias, multiple myeloma, non-hodgkin’s lymphoma

Anaadriana Zakarija

Associate Professor of Medicine (Hematology and Oncology)

The diagnosis and treatment of bleeding disorders and their complications. Evaluation of causes of thrombosis and education regarding treatment and prevention of thrombosis.

Meejeon Roh

Research Assistant Professor of Medicine (Hematology and Oncology)

Understanding prostate cancer using molecular biology approaches in combination with transgenic mouse model has

Read More →